Loading Phase
Also known as: loading dose · saturation phase
A loading phase is a period of larger initial dosing meant to reach a target drug level quickly, before switching to a smaller maintenance dose.
In pharmacology, a loading dose is a dose larger than the maintenance dose, given at the start of treatment to reach therapeutic drug concentrations quickly or to get an immediate response. It is usually given as a single dose, although some drugs, such as amiodarone or digoxin, are loaded with several doses over hours to days. After loading, a smaller maintenance dose keeps the level where the loading dose put it.
Loading exists because of steady state. With regular dosing alone, a drug takes about 4 to 5 half-lives to approach steady state (1 − 0.5^4 = 94%; 1 − 0.5^5 = 97%). For a drug with a long half-life, that can mean weeks of below-target levels, so when waiting is not acceptable, a loading dose fills the drug's volume of distribution up front. Many drugs do without it: the Zepbound (tirzepatide) label reports that steady-state concentrations were reached after 4 weeks of once-weekly dosing, starting from its lowest dose.
Why it matters
Loading doses are not a validated practice for research peptides. Designing one requires a target concentration, a volume of distribution, and a bioavailability measured in humans, and for most research peptides those numbers are not established. For BPC-157, a 2025 systematic review found 35 preclinical studies, a single retrospective human study, and no clinical safety data. "Loading weeks" in community protocols are conventions, not pharmacology.
Loading also raises the peak level (Cmax) at the moment your body has had no time to adapt. If side effects track the peak level, loading makes them more likely. Approved GLP-1 drugs go the other way: they start at their lowest dose and step up, which is titration, the opposite of loading.
How a loading dose is calculated
- Choose the target plasma concentration you want to reach.
- Find the drug's volume of distribution (Vd), the apparent volume the dose spreads into.
- Find the bioavailability (F) for the route used; F is 1 for intravenous dosing.
- Multiply the target concentration by Vd, then divide by F.
Loading dose = target concentration × Vd ÷ F
For a hypothetical drug with a target concentration of 2 mg/L, a Vd of 10 L, and an F of 0.8: 2 × 10 ÷ 0.8 = 25 mg. If you do not have human Vd and F values for a compound, this calculation cannot be done honestly.
Common mistakes
- Treating a forum "loading week" as if it were a pharmacology-based regimen.
- Loading a compound whose side effects rise with peak concentration.
- Plugging animal volume of distribution or bioavailability values into a human calculation.
- Confusing a loading phase with titration, which moves in the opposite direction.
- Forgetting that a loading dose only shortens the time to target level; it does not make the target level more effective.
Sources
- ReferenceLoading Dose. StatPearls, 2023. PMID 32491350.
- Prescribing informationZEPBOUND (tirzepatide) injection, for subcutaneous use: Prescribing Information. U.S. Food and Drug Administration, 2023.
- Systematic reviewEmerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS J, 2025. PMID 40756949.
Page updated . How we grade evidence: methodology.
Related Terms
Maintenance Dose
A maintenance dose is the regular ongoing dose that keeps a drug's level and effect steady once any titration or loading is complete.
Steady State
Steady state is the point in repeated dosing where the drug eliminated each interval equals the drug taken in, so levels stop climbing.
Titration
Titration is starting a drug at a low dose and raising it in planned steps, so your body can adjust and side effects stay manageable.
Half-Life
Half-life (t½) is the time it takes for the concentration of a drug in your blood plasma to fall by half.
Look up any peptide term inside DoseCraft Pro
The glossary is just the start. Inside DoseCraft you get 90+ compound deep-dives, a PK-aware protocol engine, interaction checker, and vendor trust scores — every term surfaced in protocol-design context, not a separate page.
Start Free Trial